Over the last 7 days, the Pharma industry has dropped 2.6%, driven by a pullback from Sanofi of 3.2%. Overall the industry is down 8.3% in 12 months. Earnings are forecast to grow by 16% annually.
Has the French Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 19 May 2024 | €126.5b | €52.9b | €5.2b | 21.6x | 24.5x | 2.4x |
Tue, 16 Apr 2024 | €123.2b | €52.7b | €6.0b | 20.2x | 20.4x | 2.3x |
Thu, 14 Mar 2024 | €124.4b | €52.6b | €6.0b | 20.5x | 20.6x | 2.4x |
Sat, 10 Feb 2024 | €122.6b | €53.0b | €6.3b | 19.5x | 19.6x | 2.3x |
Mon, 08 Jan 2024 | €131.5b | €52.2b | €9.7b | 18.4x | 13.5x | 2.5x |
Wed, 06 Dec 2023 | €121.5b | €52.2b | €9.7b | 17.3x | 12.5x | 2.3x |
Fri, 03 Nov 2023 | €123.0b | €52.2b | €9.7b | 15.9x | 12.7x | 2.4x |
Sun, 01 Oct 2023 | €142.6b | €52.6b | €9.3b | 18.6x | 15.4x | 2.7x |
Tue, 29 Aug 2023 | €139.7b | €52.6b | €9.3b | 21.2x | 15.1x | 2.7x |
Thu, 27 Jul 2023 | €135.2b | €52.6b | €9.1b | 19.6x | 14.8x | 2.6x |
Sat, 24 Jun 2023 | €137.2b | €52.6b | €9.1b | 15.4x | 15x | 2.6x |
Mon, 22 May 2023 | €141.7b | €52.6b | €9.1b | 15.9x | 15.5x | 2.7x |
Wed, 19 Apr 2023 | €140.6b | €51.8b | €9.2b | 15.5x | 15.3x | 2.7x |
Fri, 17 Mar 2023 | €126.5b | €51.7b | €9.2b | 14.8x | 13.8x | 2.4x |
Sun, 12 Feb 2023 | €125.0b | €51.7b | €7.5b | 18.5x | 16.6x | 2.4x |
Tue, 10 Jan 2023 | €127.3b | €50.7b | €7.4b | 17.5x | 17.3x | 2.5x |
Thu, 08 Dec 2022 | €127.9b | €50.7b | €7.3b | 17.6x | 17.5x | 2.5x |
Sat, 05 Nov 2022 | €124.1b | €50.7b | €7.4b | 17.1x | 16.9x | 2.4x |
Mon, 03 Oct 2022 | €111.7b | €48.4b | €7.6b | 17.1x | 14.7x | 2.3x |
Wed, 31 Aug 2022 | €118.2b | €48.2b | €7.6b | 21.9x | 15.6x | 2.5x |
Fri, 29 Jul 2022 | €137.7b | €46.3b | €7.5b | 23x | 18.4x | 3x |
Sun, 26 Jun 2022 | €139.3b | €46.3b | €7.5b | 21.9x | 18.6x | 3x |
Tue, 24 May 2022 | €143.9b | €45.4b | €7.5b | 23.5x | 19.2x | 3.2x |
Thu, 21 Apr 2022 | €142.5b | €44.2b | €7.1b | 24x | 20.2x | 3.2x |
Sat, 19 Mar 2022 | €131.1b | €44.1b | €7.1b | 20.6x | 18.5x | 3x |
Mon, 14 Feb 2022 | €130.9b | €44.1b | €7.1b | 18.9x | 18.5x | 3x |
Wed, 12 Jan 2022 | €125.4b | €43.2b | €7.0b | 20x | 17.9x | 2.9x |
Fri, 10 Dec 2021 | €119.1b | €43.2b | €7.0b | 22.2x | 17x | 2.8x |
Sun, 07 Nov 2021 | €124.4b | €43.2b | €7.0b | 21.1x | 17.8x | 2.9x |
Tue, 05 Oct 2021 | €116.7b | €42.3b | €6.6b | 18.7x | 17.6x | 2.8x |
Thu, 02 Sep 2021 | €123.4b | €42.2b | €6.6b | 21.9x | 18.7x | 2.9x |
Sat, 31 Jul 2021 | €121.8b | €42.2b | €6.6b | 20.9x | 18.5x | 2.9x |
9.3x
How does French Pharma compare with similar industries?
FR Market | -0.42% | |
Healthcare | -2.18% | |
Pharma | -4.78% | |
Pharma | -4.78% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
IPN Ipsen | €120.80 | 0.8% +€74.3m | 6.0% | PE16.2x | |
VETO Vetoquinol | €101.20 | 3.2% +€36.7m | 8.5% | PE21.6x | |
EAPI Euroapi | €3.25 | 4.8% +€14.0m | -68.7% | PS0.3x | |
AB AB Science | €2.10 | 5.5% +€5.6m | -51.2% | PS110.6x | |
ALDVI Advicenne | €2.12 | 18.2% +€4.0m | -45.3% | PS8x |